USP8

Overview

USP8 is a novel predominantly clonal driver nominated in U-CLL by the CLL map study.

Alterations observed in the corpus

  • USP8 was identified as a predominantly clonal novel driver in U-CLL in the integrated CLL map cohort PMID:35927489.

Cancer types (linked)

Co-occurrence and mutual exclusivity

  • Not reported in the corpus.

Therapeutic relevance

  • No direct targeted therapy reported in the corpus.

Open questions

  • Functional validation of USP8 as a CLL driver is deferred to future work PMID:35927489.

Sources

This page was processed by crosslinker on 2026-04-08.